PT  - JOURNAL ARTICLE
AU  - Hala Azhari
AU  - Jonathan Hewitt
AU  - Alexander Smith
AU  - Martin O’Neill
AU  - Terence Quinn
AU  - Jesse Dawson
TI  - Pioglitazone and barriers to effective post-stroke comorbidity management in stroke survivors with diabetes
AID  - 10.17712/nsj.2024.1.20230043
DP  - 2024 Jan 01
TA  - Neurosciences Journal
PG  - 44--50
VI  - 29
IP  - 1
4099  - http://nsj.org.sa/content/29/1/44.short
4100  - http://nsj.org.sa/content/29/1/44.full
SO  - Neurosciences (Riyadh)2024 Jan 01; 29
AB  - Objectives: To explore the barriers preventing pioglitazone use in stroke survivors and primary and secondary stroke care services.Methods: A qualitative grounded theory approached design was used to assess post-stroke diabetes treatments and to assess clinical applicability of pioglitazone as a preventive treatment to minimize its side effects (SEs) associated. Three focus groups were established with 48 participants from Scotland and Wales health board centers during January 2019 to July 2022.Results: A qualitative grounded theory approached design was used to assess post-stroke diabetes treatments and to assess clinical applicability of pioglitazone as a preventive treatment to minimize its SEs associated. Three focus groups were established with 48 participants from Scotland and Wales health board centers during January 2019 to July 2022.Conclusion: These strategies might allow greater treatment adherence by stroke survivors and increased confidence of the health care professionals in their practice. The findings suggest that further research will be needed to facilitate wider usage of pioglitazone in treating people with stroke and health education is necessitate when using diabetes drugs post-stroke.